AMSilk GmbH

Company

    • Company type:
      • Research & Development
    • Year founded:
    • 2008
    • Employees (at the site):
    • 25
    • Turnover range:
    • not available
    • Products/services:
    • The AMSilk®-Technology enables the production of biopolymers such as spider silk on an industrial scale. These materials are unrivaled by most common synthetic materials. AMSilk addresses many applications and industry sectors with new materials enabling new products with previously unachievable features.

      Tailor-made materials using the AMSilk®-Technology enable new and superior products with previously unachievable features, spanning multiple industries and applications

    • Core competencies:
    • not available

    • Language skills:
    • English
      German
    • Key Tech / section:
      • Biotechnology: Biomaterials
      • Biotechnology: Drug delivery
      • Biotechnology: Tissue engineering and regenerative medicine
      • Medical Technology: Implants, biomaterials, tissue engineering
      • Nanotechnology: Biocompatible materials and layers
      • Nanotechnology: Drug encapsulation, targeted drug delivery
      • New Materials: Fibers and textiles
    • Certification:
    • not available

    • Sales markets - target industries:
    • not available
    • Sales markets - target countries:
    • not available
    • Cooperation offers:
    • not available
    • Contact person:
    • Dr. Lin Römer (Mr.)
      - Management
      - Research & development